Synthesis, in-vitro microbial and cytotoxic studies of new benzimidazole derivatives

Archiv der Pharmazie

Volumn 342, Issue 7, 2009, Pages 412-419

  Harisha, Reddy S ^a   Hosamani, Kallappa M ^a   Keri, Rangappa S ^a  

^a KARNATAK UNIVERSITY   (India)

Author keywords

2 (Trifluoromethyl) 1H benzimidazole; Coumarin; Pyrazole; Thiazolidine; Triazolo thiadiazole

Indexed keywords

1 [[2 (TRIFLUOROMETHYL) 1H BENZIMIDAZOL 1 YL]METHYL] 3H BENZO [F] CHROMEN 3 ONE; 2 (1H BENZIMIDAZOLE 2 YLCARBONYL) 5 METHYL 2,4 DIHYDRO 3H PYRAZOL 3 ONE; 2 (6 METHYL [1,2,4] TRIAZOLO [3,4 B] [1,3,4] THIADIAZOL 3 YL) 1H BENZIMIDAZOLE; 2 [(3,5 DIMETHYL 1H PYRAZOL 1 YL)CARBONYL] 1H BENZIMIDAZOLE; 2 [1,2,4] TRIAZOLO [3,4 B] [1,3,4] THIADIZOL 3 YL 1H BENZIMIDAZOLE; 3 (1H BENZIMIDAZOL 2 YL) 5H [1,2,4] TRIAZOLO [3,4 B] [1,3,4] THIADIAZIN 6(7H) ONE; 3 (1H BENZIMIDAZOLE 2 YL) 6 CHLORO 7H [1,2,4] TRIAZOLE [3,4 B] [1,3,4] THIADIAZINE; 3 (1H BENZIMIDAZOLE 2 YL) [1,2,4] TRIAZOLO [3,4 B] [1,3,4] THIADIAZOLE 6 THIOL; 4 AMINO 5 (1H BENZIMIDAZOLE 2 YL) 4H [1,2,4] TRIAZOLE 3 THIOL; 6 CHLORO 4 [[ 2 (TRIFLUOROMETHYL) 1H BENZIMIDAZOL 1 YL]METHYL] 2H CHROMEN 2 ONE; 7 METHYL 4 [[2 (TRIFLUOROMETHYL) 1H BENZIMIDAZOL 1 YL]METHYL] 2H CHROMEN 2 ONE; ANTIFUNGAL AGENT; BENZIMIDAZOLE DERIVATIVE; CYTOTOXIC AGENT; N (4 OXO 2 PHENYL 1,3 THIAZOLIDIN 3 YL) 1H BENZIMIDAZOLE 2 CARBOXAMIDE; N [(2 E) 4 OXO 2 (PHENYLIMINO) 1,3 THIAZOLIDIN 3 YL] 1H BENZIMIDAZOLE 2 CARBOXAMIDE; N [(2 Z) 4 OXO 2 (PHENYLIMINO) 1,3 THIAZOLIDIN 3 YL] 1H BENZIMIDAZOLE 2 CARBOXAMIDE; NYSTATIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTEMIA; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; ARTEMIA; BACTERIA; BENZIMIDAZOLES; FUNGI; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 67650079652     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200900022     Document Type: Article

References (26)

1. J. Z. Stefanska, R. Gralewska, B. J. Starosciak, Z. Kazimierezuk, Pharmazie 1999, 54, 879-884.
2. M. Andrzejewska, M. A. Pagano, F. Meggio, A. M. Brunati, Z. Kazimierezuk, Bioorg. Med. Chem. 2003, 11, 3997-4002.
3. M. Andrzejewska, L. Yepez-Mulia, R. Cedillo-Rivera, A. Tapia, et al., Eur. J. Med. Chem. 2002, 37, 973-978.
4. Z. Kazimierezuk, J. A. Upcroft, P. Upcroft, A. Gorska, et al., Acta Biochim. Pol. 2002, 49, 185-195.
5. D. E. Burton, A. J. Lambie, J. C. Ludgate, G. T. Newbold, et al., Nature 1965, 208, 1166-1169.
6. G. Navarrete-Vazquez, R. Cedillo, A. Hernandez-Campos, L. Yepez-Mulia, et al., Bioorg. Med. Chem. Lett. 2001, 11, 187-190.
7. G. Navarrete -Vazquez, L. Yepez, A. Hernandez-Campos, A. Tapia, et al., Bioorg. Med. Chem. 2003, 11, 4615-4622.
8. D. H. Boschelli, D. T. Connor, D. A. Barnemeier, J. Med. Chem. 1993, 36, 1802-1810.
9. J. T. Witkowski, R. K. Robins, G. P. Khare, R. W. Sidwell, J. Med. Chem. 1973, 16, 935-937.
10. V. Mathew, J. Keshavayya, V. P. Vaidya, Eur. J. Med. Chem. 2006, 41, 1048-1058.
11. B. S. Holla, R. Gonsalvel, S. Shenoy, IL Farmaco 1998, 53, 574-578.
12. B. S. Holla, B. Sorojini, S. B. Rao, P. M. Akberali, et al., IL Farmaco 2001, 56, 565-570.
13. M. Kritsanida, A. Mouroutsw, P. Marakos, N. Pouli, et al., IL Farmaco 2002, 57, 253-257.
14. A. R. Surrey, J. Am. Chem. Soc. 1949, 71, 3105-3107;
15. J. Am. Chem. Soc. 1949, 71, 3354-3356.
16. K. C. Joshi, S. Giri, J. Ind. Chem. Soc. 1963, 40, 42-44.
17. J. Haglind, Chem. Abstr. 1966, 64, 16509.
18. P. Laurin, D. Ferroud, L. Schio, M. Klich, et al., Bioorg. Med. Chem. Lett. 1999, 9, 2875-2880.
19. I. A. Khan, M. V. Kulkarni, C. M. Sun, Eur. J. Med. Chem. 2005, 40, 1168-1172.
20. D. N. Nicolaides, K. C. Fylaktakidou, K. E. Litinas, D. Hadjipavlou-Litina, Eur. J. Med. Chem. 1998, 33, 715-724.
21. H. H. Adavi, R. A. Kusanur, M. V. Kulkarni, J. Ind. Chem. Soc. 2004, 81, 981-985.
22. National Committee for Clinical Laboratory Standards, NCCLS Approval Standard Document M2-A7. Villanova, PA, USA, 2000.
23. National Committee for Clinical Laboratory Standards, NCCLS Approval Standard Document M7-A5. Villanova, PA, USA, 2000.
24. H. William, Microbiological assay. An Introduction to Quantitative Principles and Evaluation, Academic Press, New York, 1977.
25. B. N. Meyer, N. R. Ferrigni, J. E. Putnam, L. B. Jacobsen, et al., Planta Med. 1982, 45, 31-34.
26. A. W. Bauer, W. M. Kirby, J. C. Sherris, M. Turck, Am. J. Clin. Pathol. 1966, 45, 493-496.